first
report
filoviru
hemorrhag
fever
outbreak
took
place
germani
former
yugoslavia
caus
agent
identifi
outbreak
marburg
viru
one
deadli
human
pathogen
articl
provid
comprehens
overview
current
knowledg
marburg
viru
diseas
rang
ecolog
pathogenesi
molecular
biolog
marburg
viru
marv
first
appear
august
laboratori
worker
marburg
frankfurt
germani
belgrad
yugoslavia
serbia
infect
previous
unknown
infecti
agent
patient
primari
six
secondari
infect
develop
sever
diseas
progress
fatal
outcom
seven
case
addit
case
show
symptom
diseas
diagnos
retrospect
review
sourc
infect
trace
back
african
green
monkey
chlorocebu
aethiop
import
uganda
ship
three
locat
primari
infect
iron
occur
monkey
necropsi
purpos
obtain
kidney
cell
cultur
poliomyel
vaccin
strain
remark
period
less
three
month
etiolog
agent
isol
character
identifi
joint
effort
open
access
scientist
marburg
hamburg
later
confirm
kunz
colleagu
kissl
colleagu
pathogen
name
marburg
viru
citi
case
repres
first
isol
filoviru
erron
studi
publish
lancet
claim
mysteri
diseas
caus
rickettsia
chlamydia
frequent
cite
first
report
caus
agent
marburg
viru
diseas
mvd
betterknown
member
famili
ebola
viru
ebov
first
emerg
africa
shortli
thereaft
marburgvirus
ebolavirus
classifi
togeth
newli
establish
famili
term
filovirida
sonam
distinct
threadlik
structur
filum
latin
thread
marv
heard
eight
year
young
australian
travel
throughout
zimbabw
admit
hospit
johannesburg
south
africa
symptom
reminisc
observ
outbreak
europ
die
infect
spread
travel
companion
later
also
nurs
lassa
fever
initi
suspect
result
strict
barrier
nurs
techniqu
isol
patient
primari
contact
lead
quick
contain
outbreak
secondari
case
recov
marv
identifi
caus
agent
diseas
follow
year
sporad
outbreak
affect
small
number
individu
caus
marv
african
contin
tabl
figur
case
fatal
rate
associ
mvd
also
lower
seen
devast
outbreak
associ
ebov
diseas
reach
marv
long
thought
less
threaten
tabl
howev
view
revis
marv
reemerg
two
larg
outbreak
occur
democrat
republ
congo
drc
first
time
also
western
africa
angola
total
number
case
high
fatal
rate
drc
angola
reveal
marv
big
threat
public
health
ebov
variat
observ
diseas
sever
case
fatal
rate
outbreak
versu
initi
one
may
depend
mani
complicatingmitig
factor
includ
qualiti
avail
medic
care
infecti
dose
rout
infect
differ
host
popul
suscept
depend
immun
nutrit
statu
genet
inher
differ
viral
variant
virul
preval
coinfect
particularli
malaria
aid
patient
subsaharan
africa
assumpt
marv
angola
might
inher
virul
marv
variant
propos
mainli
base
infect
studi
nonhuman
primat
nhp
matter
debat
genom
angolan
isol
differ
nucleotid
level
major
east
african
marv
isol
includ
one
evid
far
observ
genet
differ
result
higher
virul
human
drc
outbreak
uniqu
least
nine
differ
viru
variant
circul
test
patient
indic
sever
differ
spillov
event
natur
reservoir
human
popul
contrast
sequenc
data
angolan
outbreak
suggest
singl
introduct
marv
unidentifi
index
patient
subsequ
spread
via
persontoperson
contact
viral
genom
show
remark
high
genet
stabil
within
outbreak
ident
marv
genom
isol
patient
even
two
three
human
human
transmiss
mvd
consid
zoonot
diseas
thought
persist
healthi
reservoir
host
endem
area
africa
human
nhp
spillov
host
show
high
rate
fatal
diseas
outcom
sever
largescal
attempt
identifi
natur
host
filoviru
infect
throughout
subsaharan
africa
undertaken
year
sinc
filovirus
first
emerg
frustratingli
littl
success
consist
ecolog
nich
model
outbreak
epidemiolog
pattern
isol
case
suggest
ebov
endem
rain
forest
central
western
africa
marv
preval
open
dri
area
eastern
southcentr
africa
almost
primari
infect
natur
mvd
outbreak
far
link
human
entri
cave
inhabit
bat
eg
cave
visitor
mine
worker
tabl
thu
bat
long
suspect
play
import
role
transmiss
cycl
diseas
evid
detect
marv
infect
common
egyptian
fruit
bat
rousettu
aegyptiacu
figur
marv
isol
healthi
infect
r
aegyptiacu
bat
caught
year
uganda
bat
collect
kitaka
cave
around
time
human
infect
occur
link
cave
tabl
see
epidemiolog
genom
analysi
isol
marv
acquir
bat
show
sequenc
match
close
marv
genom
isol
patient
sampl
figur
also
case
partial
marv
sequenc
isol
bat
inhabit
goroumbwa
mine
drc
suspect
major
locat
sever
independ
spillov
event
gold
miner
bat
marv
sequenc
close
relat
distinct
isol
report
outbreak
human
studi
analyz
marv
preval
bat
popul
gabon
found
marvspecif
nucleic
acid
r
aegyptiacu
bat
sever
local
cave
togeth
previou
data
show
high
preval
marvspecif
antibodi
gabones
bat
popul
observ
relat
isol
sequenc
previous
report
gabones
bat
isol
studi
virus
suggest
marv
enzoot
gabon
rais
concern
spread
marv
countri
therefor
close
ecolog
well
serolog
surveil
bat
popul
subsaharan
africa
could
help
predict
prevent
mvd
outbreak
especi
area
bat
still
use
food
sourc
current
clear
whether
r
aegyptiacu
bat
exclus
reservoir
marv
bat
speci
report
posit
viral
antibodi
rna
also
natur
reservoir
mere
intermedi
host
genu
marburgviru
includ
singl
speci
marburg
marburgviru
formerli
refer
lake
victoria
marburgviru
phylogenet
analysi
base
genom
sequenc
data
suggest
known
member
speci
assign
least
five
differ
lineag
four
close
relat
nucleotid
sequenc
differ
fifth
diverg
nucleotid
differ
figur
genom
diverg
isol
cutoff
classif
five
differ
ebolavirus
five
differ
speciesth
five
marburgviru
lineag
recent
reclassifi
two
virus
ravn
viru
ravv
repres
ravn
isol
one
isol
drc
outbreak
one
human
sever
bat
isol
infect
took
place
uganda
marburg
viru
marv
repres
sequenc
isol
figur
tabl
sake
simplic
review
abbrevi
marv
use
marburgvirus
abbrevi
ebov
ebolavirus
initi
mvd
patient
believ
contract
viru
via
exposur
infect
anim
either
reservoir
host
sever
bat
speci
spillov
host
nhp
describ
first
mvd
outbreak
see
epidemiolog
follow
transmiss
human
spread
viru
individu
result
direct
contact
blood
bodi
fluid
saliva
sweat
stool
urin
tear
breast
milk
infect
patient
typic
risk
exposur
includ
administr
medic
care
infect
individu
well
handl
corps
without
use
proper
protect
particular
note
viru
found
tear
semen
liver
biopsi
week
month
follow
onset
symptom
highlight
import
monitor
convalesc
patient
much
know
typic
mvd
symptom
come
primarili
clinic
data
obtain
three
largest
record
mvd
outbreak
outbreak
germani
yugoslavia
outbreak
drc
outbreak
angola
although
case
fatal
rate
significantli
higher
latter
outbreak
clinic
symptom
observ
similar
base
reliabl
document
case
exposur
subsequ
ill
mvd
incub
period
rang
day
typic
day
like
modul
factor
infecti
dose
possibl
rout
infect
cours
mvd
convent
broken
three
phase
initi
gener
phase
earli
organ
phase
either
late
organ
phase
convalesc
phase
depend
upon
diseas
outcom
summari
mvd
symptom
review
onset
ill
begin
gener
flulik
symptom
characterist
high
fever
typic
c
sever
headach
chill
myalgia
prostrat
malais
mani
patient
follow
rapid
debilit
character
gastrointestin
symptom
includ
anorexia
abdomin
pain
sever
nausea
vomit
wateri
diarrhea
start
day
four
five
patient
commonli
develop
enanthem
dysphasia
pharyng
addit
characterist
maculopapular
rash
typic
first
distinct
featur
indic
filoviru
infect
versu
influenza
malaria
common
symptom
includ
lymphadenopathi
leukopenia
thrombocytopenia
mani
initi
symptom
may
persist
earli
organ
phase
patient
may
sustain
high
fever
may
addit
display
neurolog
symptom
includ
enceph
confus
delirium
irrit
aggress
patient
also
develop
dyspnea
abnorm
vascular
permeabl
particularli
conjunctiv
inject
edema
latter
part
phase
patient
present
form
clear
hemorrhag
manifest
petechia
mucos
bleed
melena
bloodi
diarrhea
hematemesi
ecchymos
due
unusu
hemorrhag
symptom
diseas
caus
filovirus
sometim
refer
hemorrhag
fever
marburg
hemorrhag
fever
mhf
ebola
hemorrhag
fever
ehf
although
term
current
disfavor
sinc
patient
display
hemorrhag
symptom
stage
multipl
organ
affect
includ
pancrea
kidney
liver
elev
serum
activ
number
liver
enzym
includ
sgot
sgpt
observ
patient
sampl
late
stage
mvd
result
one
two
potenti
outcom
patient
either
succumb
diseas
enter
prolong
phase
recuper
typic
preagon
symptom
includ
restless
obtund
confus
dementia
convuls
reduc
circul
due
sever
dehydr
metabol
disturb
sever
diffus
coagulopathi
multiorgan
failur
shock
coma
fatal
typic
occur
day
follow
onset
symptom
death
usual
result
shock
multiorgan
failur
nonfat
case
typifi
extens
convalesc
period
myalgia
exhaust
sweat
peel
skin
site
rash
partial
amnesia
secondari
infect
common
prevent
newli
emerg
marv
infect
effect
contain
ongo
outbreak
essenti
challeng
current
licens
vaccin
treatment
avail
gener
use
follow
outbreak
mvd
europ
case
infect
ebolaviru
reston
import
crabeat
macaqu
macaca
fasciculari
usa
well
itali
review
strict
quarantin
procedur
put
place
far
prevent
infect
acquir
import
nhp
nonendem
countri
avoid
spread
filovirus
tourist
python
cave
close
public
follow
diagnosi
dutch
patient
prevent
control
outbreak
infect
endem
countri
much
challeng
past
joint
effort
team
doctor
without
border
red
cross
cdc
other
collabor
local
ministri
health
undertaken
ceas
spread
mvd
main
focu
outbreak
control
prevent
secondari
transmiss
primari
infect
first
measur
respons
mvd
outbreak
includ
set
isol
ward
hospit
assur
rapid
isol
marvinfect
patient
prevent
persontoperson
transmiss
figur
proper
fast
laboratori
diagnosi
suspect
case
key
elimin
spread
nosocomi
infect
commonli
seen
earlier
outbreak
howev
reinforc
barrier
nurs
techniqu
educ
health
care
worker
limit
infect
recent
outbreak
figur
epidemiolog
surveil
crucial
identif
index
case
well
predomin
mode
transmiss
endem
area
secondari
infect
mainli
occur
take
care
ill
patient
famili
member
tradit
burial
practic
involv
close
contact
corps
therefor
execut
safe
burial
disinfect
techniqu
inform
campaign
educ
local
popul
essenti
order
contain
spread
infect
endem
area
figur
biosafeti
epidemiolog
effort
alon
suffici
effici
outbreak
control
larg
outbreak
emphas
need
addit
psychosoci
support
affect
commun
fast
progress
high
lethal
rate
associ
mvd
evenand
especiallyaft
hospit
admiss
result
high
level
fear
suspicion
resid
popul
fact
health
care
worker
wear
recommend
person
protect
equip
ppe
fulli
mask
identifi
increas
anxieti
figur
result
hide
infect
famili
member
verbal
case
physic
aggress
toward
member
aid
organ
commun
necessari
protect
measur
respect
consid
affect
famili
commun
tradit
cultur
ongo
outbreak
therefor
essenti
success
outbreak
manag
recent
identif
bat
potenti
reservoir
marv
well
ebov
help
increas
public
awar
also
effect
prevent
measur
taken
endem
area
minim
contact
infect
anim
ie
close
bat
inhabit
cave
public
serosurveil
bat
popul
challeng
task
emphas
fact
last
cluster
marv
infect
link
gold
mine
uganda
miner
hire
enforc
restrict
access
mine
got
infect
mine
close
respons
ongo
outbreak
even
though
awar
risk
enter
mine
without
suggest
ppe
later
bat
popul
mine
elimin
owner
mean
fumig
bat
speci
endang
seem
viabl
option
educ
campaign
aim
villag
live
close
batinhabit
cave
well
tourist
group
tour
oper
might
prove
sustain
futur
first
report
filoviru
diseas
outbreak
europ
identif
previous
unknown
caus
agent
deadli
diseas
perform
electron
microscopi
em
figur
unusu
filament
structur
particl
led
confus
even
suggest
caus
agent
diseas
might
relat
spiralshap
leptospira
genu
spirochaet
bacteria
other
conclud
observ
particl
virus
morpholog
relat
rhabdovirus
name
newli
discov
pathogen
marburg
viru
marburg
virion
pleomorph
particl
appear
rodor
ringlik
crookor
sixshap
branch
structur
cryoem
analysi
purifi
virion
show
viral
particl
releas
infect
vero
cell
filament
sixshap
round
studi
reveal
mean
particl
length
nm
mean
diamet
nm
previou
convent
em
studi
show
marv
particl
uniformli
nm
diamet
wherea
length
vari
wide
virion
measur
nm
averag
particl
length
nm
report
differ
particl
size
might
due
experiment
differ
cryoem
convent
em
notabl
marv
particl
consider
shorter
ebov
virion
although
marv
genom
slightli
longer
ebov
genom
marv
particl
surround
hostderiv
membran
coat
spike
nm
length
form
trimer
viral
glycoprotein
gp
figur
central
core
viral
particl
ribonucleoprotein
complex
nucleocapsid
form
viral
rna
genom
tightli
associ
nucleocapsid
protein
figur
nucleocapsid
highli
organ
tubular
structur
outer
diamet
nm
electrondens
central
axi
nm
central
axi
surround
helic
capsid
crossstriat
nm
interv
recent
publish
detail
cryoelectron
tomographi
analysi
marv
virion
shed
light
structur
organ
nucleocapsid
reconstruct
virionassoci
nucleocapsid
use
subtomogramaverag
analysi
reveal
marv
nucleocapsid
form
lefthand
helix
pitch
nm
flexibl
averag
symmetri
protrus
per
turn
two
inner
lobe
densiti
per
protrus
inner
lobe
repres
nucleoprotein
np
suggest
marv
nucleocapsid
contain
averag
number
np
molecul
per
turn
np
molecul
packag
six
rna
base
marv
nucleocapsid
show
direction
point
barb
tip
nonseg
negativesens
nn
rna
genom
variou
marv
isol
rang
size
nt
contain
seven
monocistron
gene
linear
order
figur
gene
compos
highli
conserv
transcript
start
stop
signal
unusu
long
untransl
region
open
read
frame
orf
gene
either
separ
short
intergen
region
rang
nt
transcript
stop
signal
upstream
gene
transcript
start
signal
downstream
gene
overlap
share
five
highli
conserv
nt
figur
structur
gene
overlap
found
among
filovirus
uniqu
among
member
order
mononegaviral
review
see
genom
end
extracistron
regulatori
region
contain
cisact
signal
essenti
transcript
replic
includ
transcript
replic
promot
gener
two
type
genom
replic
promot
nn
rna
virus
bipartit
promot
found
member
paramyxoviru
subfamili
paramyxovirina
one
continu
compact
replic
promot
rhabdoand
pneumovirus
bipartit
promot
structur
paramyxovirina
subfamili
associ
rule
six
ie
total
genom
length
must
multipl
six
given
filovirus
obey
rule
six
surpris
map
marv
genom
replic
promot
reveal
bipartit
structur
genom
end
leader
compris
nt
contain
first
promot
element
bipartit
genom
replic
promot
second
promot
element
consist
unnnnn
motif
three
conserv
uridin
residu
separ
five
nonconserv
nucleotid
un
hexam
locat
within
untransl
region
first
marv
gene
np
gene
separ
first
promot
region
nt
long
transcript
start
signal
substitut
np
transcript
start
signal
affect
replic
activ
interfer
transcript
initi
extracistron
region
trailer
span
last
nt
marv
genom
contain
complement
antigenom
replic
promot
see
transcript
replic
structur
marv
antigenom
promot
yet
determin
howev
due
presenc
un
hexam
like
bipartit
natur
similar
genom
promot
common
featur
leader
trailer
region
nn
rna
virus
high
degre
complementar
termin
nucleotid
although
filovirus
share
featur
leader
trailer
also
capabl
form
intern
secondari
structur
case
leader
trailer
nn
rna
virus
marv
genom
encod
seven
structur
protein
list
tabl
marv
singl
surfac
protein
gp
encod
fourth
gene
mediat
attach
target
cell
viru
entri
gp
type
transmembran
protein
insert
viral
envelop
form
homotrimer
spike
contrast
ebolavirus
use
transcript
edit
express
membranebound
gp
least
two
nonstructur
glycoprotein
marv
gp
gene
contain
singl
open
read
frame
orf
encod
fulllength
gp
transport
endoplasm
reticulum
er
plasma
membran
via
secretori
pathway
precursor
gp
target
variou
posttransl
modif
includ
glycosyl
acyl
phosphoryl
gp
heavili
glycosyl
complex
high
mannosetyp
nlink
glycan
well
mucintyp
olink
glycan
carbohydr
contribut
appar
molecular
weight
protein
similar
ebov
gp
olink
glycan
mani
nlink
oligosaccharid
cluster
mucinlik
domain
synthesi
er
precursor
gp
cleav
amino
acid
furin
furinlik
proteas
tran
golgi
network
result
two
disulfidelink
subunit
gp
kd
gp
kd
ectodomain
mainli
form
gp
mediat
bind
entri
factor
receptor
transmembran
subunit
gp
contain
fusion
peptid
presum
mediat
fusion
viral
cellular
membran
base
similar
ebov
gp
amino
acid
structur
level
amino
acid
long
transmembran
domain
gp
requir
incorpor
gp
virion
addit
cytoplasm
tail
gp
involv
enhanc
effici
viral
entri
maintain
structur
ectodomain
receptor
bind
domain
marv
gp
map
aminotermin
region
gp
span
amino
acid
wherea
highli
glycosyl
mucinlik
domain
essenti
viru
entri
import
step
marv
entri
proteolyt
activ
gp
endosom
proteas
facilit
bind
receptor
bind
region
endosom
entri
factor
niemannpick
protein
see
entri
besid
function
entri
bud
gp
may
also
play
role
immun
evas
ifninduc
antivir
protein
tetherin
shown
block
releas
viruslik
marv
ebov
particl
suggest
tetherin
might
act
restrict
factor
filoviru
releas
howev
coexpress
gp
suffici
counteract
antivir
activ
tetherin
yet
unknown
mechan
possibl
gp
subvert
innat
immun
respons
also
suppress
adapt
immun
respons
filovir
gp
subunit
includ
marv
gp
contain
domain
resembl
immunosuppress
motif
found
retrovir
envelop
protein
peptid
correspond
put
immunosuppress
domain
marv
gp
shown
induc
lymphocyt
death
suppress
cytokin
respons
yet
known
motif
play
role
induct
lymphocyt
apoptosi
observ
marv
infect
final
suggest
shed
ectodomain
membranebound
ebov
gp
tumor
necrosi
factor
enzym
tace
may
play
role
block
activ
neutral
antibodi
infect
report
marv
consider
amount
gp
shed
infect
cell
although
clear
marv
gp
target
tace
cleavag
matrix
protein
encod
third
marv
gene
counterpart
protein
nn
rna
virus
play
major
role
format
virion
redistribut
nucleocapsid
perinuclear
region
plasma
membran
recruit
gp
site
bud
mediat
particl
releas
overexpress
led
reduc
report
gene
express
marv
minigenom
suggest
regulatori
role
transcript
andor
replic
peripher
membran
protein
coat
inner
side
virion
membran
figur
cryoem
tomographi
studi
suggest
associ
nucleocapsid
flexibl
interact
easili
remov
nucleocapsid
salt
dissoci
indic
loos
connect
nucleocapsid
synthesi
cytoplasm
infect
cell
associ
rapidli
cellular
membran
accumul
membran
structur
late
endosom
compart
multivesicular
bodi
minor
portion
also
found
associ
viral
nucleocapsid
inclus
addit
appear
patch
beneath
plasma
membran
transport
via
retrograd
late
endosom
pathway
similar
ebov
marv
major
factor
particl
format
bud
express
absenc
viral
protein
lead
format
releas
filament
viruslik
particl
vlp
resembl
authent
virion
process
enhanc
presenc
gp
role
bud
describ
detail
see
bud
compar
ebov
littl
known
structur
marv
ntermin
domain
marv
fold
ringlik
structur
tendenc
polymer
rodlik
structur
ebov
shown
form
hexam
octam
stoichiometri
marv
oligom
known
marv
phosphoryl
sever
tyrosin
residu
locat
ntermin
region
protein
nonphosphorylat
mutant
impair
abil
recruit
nucleocapsid
site
bud
still
abl
effici
induc
particl
releas
also
possess
pppi
late
domain
motif
amino
terminu
import
interact
compon
endosom
sort
complex
requir
transport
escrt
machineri
order
mediat
bud
includ
tumor
suscept
gene
membranebound
ubiquitin
ligas
besid
pppi
motif
motif
singl
amino
acid
found
import
particl
releas
besid
role
classic
matrix
protein
marv
also
act
virul
factor
counteract
innat
immun
respons
determin
host
tropism
marv
marv
block
phosphoryl
janu
kinas
play
import
role
multipl
signal
pathway
phosphoryl
activ
stat
protein
figur
marvinfect
cell
treat
variou
stimuli
includ
shown
stat
protein
neither
phosphoryl
transloc
nucleu
shown
marvinfect
cell
treat
exogen
stimuli
janu
kinas
also
phosphoryl
identifi
viral
protein
inhibit
ifn
signal
believ
target
howev
mechan
inhibit
complet
understood
intriguingli
ebov
also
abl
block
ifn
signal
employ
complet
differ
mechan
ebov
block
nuclear
transloc
phosphoryl
stat
protein
bind
importin
involv
nuclear
transport
specif
stat
protein
figur
review
marv
adapt
nonor
less
permiss
anim
mous
guinea
pig
adapt
virus
show
mutat
two
amino
acid
chang
mouseadapt
marv
shown
essenti
inhibit
ifn
signal
mous
cell
underlin
import
ifn
suppress
virul
host
specif
marv
protein
product
sixth
gene
uniqu
filoviru
famili
gener
address
second
minor
matrix
protein
howev
cryoelectron
tomographi
analysi
viral
particl
show
locat
close
proxim
nucleocapsid
protein
suggest
might
part
nucleocapsid
complex
easili
releas
virionassoci
nucleocapsid
treatment
increas
salt
concentr
indic
loos
connect
nucleocapsid
intracellular
local
studi
show
minor
part
protein
approx
weakli
bound
cellular
membran
includ
filopodia
enrich
also
distribut
diffus
cytoplasm
reloc
nucleocapsidcontain
inclus
found
associ
free
nucleocapsid
coexpress
np
suffici
direct
np
inclus
cytoplasm
function
studi
marv
suggest
protein
import
releas
viral
particl
context
infect
although
influenc
neither
morpholog
vlp
effici
vlp
releas
addit
rnaimedi
knockdown
marvinfect
cell
impact
viral
genom
replic
indic
involv
step
replic
bud
accord
model
propos
base
data
involv
matur
transportcompet
nucleocapsid
andor
mediat
interact
nucleocapsid
bud
site
plasma
membran
also
evid
marv
affect
transcript
replic
transcript
replic
compet
vlp
system
structur
inform
marv
limit
shown
form
oligom
preferenti
tetram
structur
predict
studi
propos
ancestr
link
armadillo
repeat
famili
marv
nucleocapsid
complex
consist
genom
rna
four
tightli
associ
protein
np
l
figur
encapsid
viral
rna
nucleocapsid
protein
protect
rnase
degrad
detect
cellular
pattern
recognit
receptor
similar
genom
rna
antigenom
rna
replic
intermedi
also
encapsid
nucleocapsid
protein
see
transcript
replic
contrast
viral
mrna
encapsid
nucleocapsid
rather
nake
rna
serv
templat
viral
transcript
replic
marv
minigenom
system
np
l
essenti
transcript
replic
role
marv
transcript
replic
well
understood
step
genom
amplif
requir
requir
yet
defin
nucleoprotein
np
enwrap
genom
antigenom
rna
replic
transcript
activ
marv
minigenom
system
depend
presenc
np
np
express
absenc
nucleocapsid
protein
selfassembl
highli
organ
helic
tubular
structur
resembl
nucleocapsid
infect
cell
indic
drive
forc
nucleocapsid
format
recent
shown
conserv
ntermin
residu
marv
np
suffici
form
helic
structur
nucleocapsid
core
inde
np
serv
viral
hub
protein
form
interact
viral
protein
lead
subcellular
redistribut
protein
strong
bind
np
nucleocapsid
protein
redirect
protein
npderiv
inclus
bipartit
coiledcoil
motif
central
part
np
shown
play
import
role
selfassembl
interact
mention
also
weak
interact
np
lead
partial
reloc
npcontain
inclus
addit
np
interact
import
transport
newli
synthes
nucleocapsid
plasma
membran
interestingli
np
contain
ctermin
late
domain
motif
psap
shown
requir
bud
np
recruit
compon
escrt
complex
late
domain
motif
lead
enhanc
bud
np
heavili
phosphoryl
serin
threonin
residu
cluster
seven
region
ctermin
part
protein
phosphoryl
form
np
incorpor
virion
recent
studi
suggest
phosphoryl
level
region
ii
modul
transcript
andor
replic
activ
polymeras
cofactor
essenti
transcript
replic
togeth
catalyt
subunit
l
form
rnadepend
rna
polymeras
complex
tightli
associ
np
serv
bridg
protein
nucleocapsid
complex
l
without
l
associ
nucleocapsid
serv
templat
viral
transcript
replic
form
homooligom
mediat
coiledcoil
motif
locat
ntermin
part
protein
homooligomer
essenti
interact
l
need
redistribut
npderiv
inclus
share
mani
featur
phospho
p
protein
nn
rna
virus
includ
posit
second
gene
viral
genom
role
transcript
replic
howev
contrast
p
protein
either
weakli
phosphoryl
besid
function
transcript
replic
marv
act
ifn
antagonist
impact
ebov
host
antivir
respons
intens
investig
review
much
less
inform
avail
similar
function
marv
test
marv
abil
block
ifn
induct
report
gene
assay
block
report
gene
express
effici
ebov
unpublish
data
addit
bosio
colleagu
report
express
marv
absenc
viral
protein
suffici
complet
block
induct
stimul
human
dendrit
cell
besid
abil
inhibit
induct
type
ifn
ebov
shown
block
activ
antivir
protein
pkr
interfer
rna
silenc
pathway
importantli
ebov
dsrna
bind
protein
cterminu
ebov
contain
domain
patch
basic
amino
acid
import
dsrna
bind
protein
inhibitori
function
review
see
ctermin
region
socal
ifn
inhibitori
domain
conserv
marv
suggest
marv
possess
similar
inhibitori
function
marv
ebov
protein
show
mani
structur
similar
marv
ebov
protein
tightli
associ
nucleocapsid
via
bind
np
figur
highli
phosphoryl
ntermin
locat
serin
threonin
residu
phosphoryl
crucial
interact
np
contain
unusu
zn
bind
domain
essenti
function
ebov
transcript
initi
factor
whose
function
relev
marv
known
also
shown
ebov
form
hexam
bind
singlestrand
rna
interact
l
howev
date
similar
data
marv
avail
role
marv
viral
transcript
replic
well
understood
contrast
ebov
play
import
role
regul
transcript
initi
marv
essenti
transcript
replic
activ
marv
minigenom
system
nevertheless
seem
play
import
role
viral
amplif
sinc
rescu
fulllength
marv
clone
success
presenc
addit
downregul
rna
interfer
marvinfect
cell
led
reduct
viral
protein
synthesi
virion
product
among
nn
rna
virus
member
subfamili
pneumovirina
possess
protein
similar
function
transcript
process
factor
major
compon
marv
polymeras
complex
l
estim
molecular
weight
kd
essenti
transcript
replic
togeth
form
rnadepend
rna
polymeras
complex
see
viral
protein
l
contain
enzymat
function
polymeras
bind
site
map
ntermin
amino
acid
residu
l
l
protein
nn
rna
virus
highli
conserv
multifunct
protein
organ
function
domain
base
conserv
nn
rna
polymeras
marv
l
believ
carri
rna
synthesi
cap
polyadenyl
viral
mrna
although
function
shown
experiment
date
studi
character
marv
replic
cycl
util
recombin
system
allow
experi
perform
biosafeti
level
context
unfett
restrict
set
surrog
system
mimick
specif
step
marv
replic
cycl
includ
marv
gppseudotyp
retrovirus
recombin
vesiculovirus
express
gp
studi
entri
vlp
studi
bud
minigenom
system
studi
replic
transcript
experi
allow
facil
examin
marv
replic
cycl
find
must
recapitul
infecti
marv
sinc
surrog
system
lack
element
infecti
viru
distinct
morpholog
featur
virion
protein
composit
marv
marburg
viru
entri
consist
three
distinct
phase
cellular
attach
endocytosi
fusion
figur
base
sequenc
similar
ebov
marv
gp
mani
investig
presum
ident
function
characterist
filoviru
glycoprotein
presumptu
given
differ
glycosyl
sialic
acid
linkag
depend
upon
endosom
proteas
see
endocytosi
despit
exist
number
detail
studi
structur
analys
ebov
gp
rel
mechanist
studi
marv
gp
perform
although
one
recent
postfus
structur
marv
gp
report
structur
marv
gp
nearli
ident
ebov
gp
indic
mechan
fusion
two
virus
like
conserv
gp
cleav
endosom
proteas
facilit
bind
entri
receptor
fusion
mediat
phdepend
manner
gp
follow
releas
viral
nucleocapsid
cytosol
transcript
viral
genom
take
place
mrna
subsequ
translat
host
cell
machineri
synthesi
gp
take
place
er
undergo
multipl
posttransl
modif
way
classic
secretori
pathway
posit
sens
antigenom
synthes
incom
viral
genom
intermedi
product
serv
templat
replic
new
neg
sens
genom
cleavag
golgi
gp
transport
multivesicular
bodi
mvb
cell
membran
bud
take
place
nucleocapsid
also
recruit
site
viral
bud
driven
marv
gp
mediat
cell
attach
fusion
viru
convinc
evid
initi
viru
attach
cell
surfac
occur
via
bind
gp
carbohydr
variou
cellular
ctype
lectin
includ
hepatocytespecif
asgpr
dcsign
dcsignr
also
known
lsign
hmgl
lsectin
cell
surfac
protein
also
implic
facilit
marv
entri
includ
tam
receptor
protein
kinas
dtk
mer
howev
although
protein
may
play
role
attach
entri
certain
cell
type
abil
marv
infect
cell
lack
receptor
indic
might
redund
cellular
molecul
requir
marv
attach
cell
number
key
residu
ebov
gp
involv
virion
incorpor
gpmediat
entri
identifi
found
play
similar
role
marv
gp
indic
virus
might
util
similar
mechan
enter
cell
follow
attach
marburg
virion
undergo
endocytosi
mediat
mechan
current
remain
undetermin
figur
initi
studi
investig
caveolinmedi
endocytosi
show
deplet
host
cell
cholesterol
reduc
viral
infect
present
direct
evid
caveola
involv
addit
studi
examin
role
caveola
ebov
endocytosi
conflict
major
role
clathrin
marv
entri
also
propos
base
upon
abil
chlorpromazin
inhibitor
clathrinmedi
endocytosi
macropinocytosi
well
rnaiknockdown
clathrin
heavi
chain
inhibit
marv
gppseudotyp
entri
caveat
analys
marv
endocytosi
perform
context
marv
gppseudotyp
retrovirus
lack
characterist
filament
morpholog
size
marburg
virion
report
verifi
cholesterol
import
live
marv
particl
uptak
canon
caveolaeand
clathrinmedi
mechan
unlik
primari
mechan
marv
entri
due
steric
issu
typic
marv
particl
size
averag
nm
much
larger
canon
caveola
nm
clathrinco
pit
nm
wherea
pseudotyp
murin
leukemia
viru
mlv
nm
vesicular
stomat
viru
vsv
nm
find
indic
involv
caveolaeand
clathrinmedi
endocyt
pathway
viru
entri
may
therefor
result
artifici
natur
pseudotyp
virion
highlight
need
confirm
experi
live
marv
macropinocytosi
identifi
major
entri
pathway
ebov
research
use
morpholog
relev
vlp
live
ebov
although
none
analys
examin
role
pathway
marv
entri
remain
intrigu
possibl
given
cholesteroldepend
larg
size
macropinocytot
vesicl
anoth
import
process
marv
entri
believ
occur
virion
traffick
within
endocyt
vesicl
proteolyt
cleavag
gp
endosom
cleavag
gp
shown
critic
effici
entri
marv
current
model
marv
entri
involv
cleavag
gp
host
endosom
cystein
proteas
remov
larg
portion
gp
includ
mucinlik
domain
believ
expos
put
receptorbind
domain
base
studi
conduct
ebov
gp
studi
examin
role
endosom
proteas
entri
marv
ebov
produc
mix
result
experi
analyz
recombin
vsv
express
ebov
gp
indic
primari
role
cathepsin
b
catb
minor
role
cathepsin
l
catl
entri
recombin
vsv
particl
contain
marv
gp
inhibit
cell
treat
inhibitor
catb
catl
report
confound
report
conduct
infecti
marburg
ebola
virus
catb
catl
inhibitor
greatli
reduc
ebov
infect
show
mix
result
marv
yet
two
recent
analys
determin
catb
requir
marv
entri
although
overexpress
enhanc
infect
catl
requir
entri
mous
embryon
fibroblast
vero
cell
cell
human
macrophag
data
well
abil
proteas
greatli
diminish
marv
infect
indic
although
catb
catl
like
play
role
cleavag
activ
gp
certain
cell
type
endosom
proteas
may
also
abl
facilit
gp
activ
via
cleavag
recent
two
independ
studi
elegantli
show
requir
endosom
cholesterol
transport
niemannpick
entri
marv
gppseudotyp
virus
vsv
mlv
well
infecti
marv
also
shown
catalyt
activ
requir
ebov
infect
indic
specif
bind
rather
role
cholesterol
transport
requir
although
test
marv
one
studi
identifi
marv
entri
receptor
also
determin
member
homotyp
fusion
vacuol
proteinsort
hop
complex
import
ebov
entri
although
appear
play
less
import
role
marv
entri
current
model
ebov
marv
fusion
gp
cleavag
endosom
proteas
remov
heavili
glycosyl
domain
expos
receptor
bind
domain
gp
enabl
bind
membranebound
fusogen
gp
undergo
low
phdepend
rearrang
extend
conform
result
fusion
virion
endolysosom
membran
support
phdepend
gpmediat
fusion
pretreat
cell
ammonium
chlorid
prevent
entri
marv
gppseudotyp
viru
recent
report
live
marv
show
ammonium
chlorid
inhibit
entri
replic
bafilomycin
specif
inhibit
vacuolartyp
h
atpas
prevent
reacidif
vesicl
central
vacuolar
system
surprisingli
effect
follow
viral
fusion
endosom
membran
nucleocapsid
releas
cytoplasm
figur
nucleocapsid
releas
cytoplasm
infect
cell
transcript
replic
viral
rna
genom
take
place
figur
first
morpholog
sign
viral
replic
observ
em
analysi
appear
granular
materi
contain
rna
viral
protein
cytoplasm
infect
cell
h
post
infect
later
tubular
structur
detect
granular
materi
repres
newli
synthes
nucleocapsid
embed
viral
inclus
experiment
data
site
marv
replic
transcript
avail
recent
studi
ebov
shown
viral
replic
take
place
inclus
transcript
observ
prior
inclus
format
encapsid
negativesens
rna
genom
transcrib
result
seven
monocistron
mrna
viral
polymeras
cotranscript
cap
polyadenyl
subsequ
translat
cellular
machineri
figur
genom
rna
also
serv
templat
product
positivesens
antigenom
complementari
copi
genom
antigenom
encapsid
nucleocapsid
protein
turn
use
templat
genom
synthesi
figur
review
see
mention
np
l
probabl
need
viral
transcript
replic
analog
ebov
conceiv
inhibit
transcript
replic
hypothes
neg
regul
replic
convert
activ
polymeras
complex
inact
state
result
matur
transportcompet
nucleocapsid
follow
assembl
newli
synthes
nucleocapsid
recruit
site
viru
bud
figur
releas
viral
particl
mainli
mediat
via
recruit
nucleocapsid
inclus
plasma
membran
recruit
gp
site
bud
induc
format
releas
filament
vlp
bud
enhanc
np
gp
case
mani
virus
marv
exploit
vesicular
transport
machineri
infect
cell
viral
egress
includ
copii
vesicular
transport
system
escrt
machineri
copii
vesicular
transport
system
use
intracellular
traffick
multivesicular
bodi
marv
bud
take
place
cellular
protein
promot
particl
releas
link
escrt
machineri
includ
marv
bud
take
place
intern
membran
also
plasma
membran
cell
cultur
marv
particl
preferenti
releas
filopodia
filament
cellular
protrus
filopodia
use
cell
explor
extracellular
environ
includ
neighbor
cell
believ
viral
particl
bud
directli
adjac
cell
via
filopodiamedi
celltocel
contact
bud
filopodia
depend
actin
sensit
depolymer
microtubul
marv
bud
observ
basolater
membran
polar
epitheli
cell
hepatocyt
wherea
viral
particl
predominantli
releas
apic
membran
infect
endotheli
cell
suggest
celltyp
specif
compon
determin
site
viru
releas
electron
tomographi
studi
marvinfect
cell
led
follow
model
marv
particl
releas
bud
process
initi
intracellular
nucleocapsid
associ
later
plasma
membran
start
one
end
nucleocapsid
subsequ
wrap
plasma
membran
viral
particl
protrud
vertic
cell
surfac
releas
infecti
filament
marv
cultur
cell
peak
day
post
infect
cell
still
intact
post
infect
cell
vesicul
releas
virion
round
bent
infect
decreas
determin
nucleocapsid
orient
site
bud
reconstruct
reveal
point
tip
bud
nucleocapsid
orient
toward
membran
indic
marv
bud
direct
marv
infect
usual
occur
direct
contact
infect
bodi
fluid
direct
person
contact
infect
anim
human
virus
enter
bodi
small
skin
lesion
mucos
membran
review
cell
mononuclear
phagocyt
system
includ
monocyt
macrophag
dendrit
cell
earli
target
cell
marv
shown
differ
experiment
anim
model
marv
replic
observ
earli
hour
post
infect
macrophag
infect
guinea
pig
infect
monocyt
found
cynomolgu
macaqu
day
post
infect
monocyt
macrophag
also
identifi
earli
target
cell
human
patient
confirm
cell
cultur
experi
show
primari
human
monocyt
macrophag
highli
suscept
marv
infect
produc
infecti
viru
addit
primari
human
monocytederiv
dendrit
cell
mdc
endotheli
cell
support
marv
replic
earli
site
viru
replic
lymph
node
liver
spleen
sever
necrot
lesion
observ
organ
contain
high
number
monocyt
macrophag
migrat
infect
monocyt
macrophag
surround
tissu
transport
free
viru
via
lymphor
bloodstream
believ
facilit
dissemin
multipl
organ
result
system
infect
cellfre
viru
observ
tissu
organ
infect
anim
high
level
viru
detect
blood
besid
monocyt
macrophag
dendrit
cell
wide
rang
cell
type
includ
hepatocyt
adren
cortic
medullari
cell
fibroblast
permiss
marv
infect
endotheli
cell
late
target
cell
marv
infect
multipl
tissu
whether
replic
marv
endotheli
cell
associ
observ
vascular
impair
mvd
matter
debat
low
number
infect
endotheli
cell
observ
nhp
infect
therefor
chang
endothelium
like
caus
paracrin
effect
cytokin
late
stage
infect
marv
particl
isol
nearli
everi
organ
despit
high
viral
load
necrot
lesion
minor
inflamm
observ
infect
tissu
organ
indic
dysregul
immun
respons
strong
liver
patholog
observ
includ
increas
serum
activ
liver
enzym
might
influenc
synthesi
clot
factor
contribut
observ
coagul
defect
mvd
factor
togeth
system
viru
replic
associ
patholog
probabl
trigger
multiorgan
failur
associ
fatal
case
although
lymphocyt
suscept
marv
infect
massiv
bystand
lymphocyt
apoptosi
hallmark
mvd
howev
molecular
mechan
lymphocyt
deplet
role
may
play
pathogenesi
mvd
far
understood
cytokin
secret
may
play
role
induct
lymphocyt
apoptosi
sinc
marvinfect
cell
secret
cytokin
known
induc
apoptosi
includ
increas
level
observ
infect
rhesu
macaqu
mice
although
increas
observ
infect
cynomolgu
macaqu
elev
level
may
also
play
role
format
endotheli
gap
context
marv
infect
addit
increas
surviv
marvinfect
guinea
pig
treat
antibodi
suggest
inde
play
import
role
mvd
pathogenesi
increas
serum
level
addit
proinflammatori
cytokin
chemokin
observ
infect
nhp
mice
report
data
complet
consist
cytokin
chemokin
secret
also
observ
infect
primari
human
monocyt
macrophag
howev
data
cytokin
level
serum
marvinfect
patient
avail
high
level
cytokin
observ
ebovinfect
patient
upregul
proinflammatori
cytokin
mediat
fever
acut
inflammatori
respons
chemoattract
neutrophil
macrophag
consist
found
infect
nhp
macrophag
plasmacytoid
dendrit
cell
pdc
serv
main
sourc
secret
spleen
primari
human
monocyt
macrophag
produc
infect
elev
level
also
detect
marvinfect
mice
increas
level
mrna
secret
protein
detect
primari
human
cell
contradictori
data
report
nhp
model
one
studi
report
elev
level
final
diseas
stage
wherea
chang
observ
anoth
studi
level
elev
infect
nhp
mice
howev
chang
level
detect
anoth
studi
infect
nhp
unclear
whether
observ
differ
due
differ
marv
variant
use
studi
serum
level
sever
chemokin
also
found
elev
marv
infect
nhp
mice
includ
macrophag
inflammatori
protein
mip
monocyt
chemotact
protein
involv
multipl
cell
type
along
possibl
role
noninfect
cell
secret
cytokin
complic
analysi
exist
data
primari
human
monocyt
macrophag
activ
marv
infect
induc
secret
cytokin
induct
cytokin
also
describ
use
uvinactiv
marv
suggest
viral
replic
might
need
observ
cytokin
increas
contrast
marvinfect
mdc
show
upregul
activ
marker
secret
cytokin
fail
stimul
cell
mdc
treat
vlp
contain
marv
gp
show
function
mdc
respons
includ
cytokin
secret
indic
marv
replic
requir
inhibit
mdc
activ
howev
infect
mdc
marv
prevent
lpsinduc
product
wherea
dsrnadepend
secret
inhibit
suggest
differenti
regul
cytokin
marv
interestingli
pdc
spleen
identifi
major
sourc
secret
marv
infect
nhp
secret
like
occur
noninfect
cell
shown
ebov
pdc
product
infect
due
impair
viral
entri
result
suggest
secret
cytokin
noninfect
bystand
cell
might
play
import
role
marv
pathogenesi
taken
togeth
marv
infect
induc
increas
product
proinflammatori
cytokin
high
level
chemokin
molecular
mechan
caus
chang
well
understood
date
four
differ
anim
model
establish
marv
infect
nhp
mice
guinea
pig
hamster
nhp
model
best
reflect
symptom
patholog
observ
human
case
describ
clinic
manifest
review
uniform
lethal
cynomolgu
rhesu
macaqu
well
african
green
monkey
diseas
symptom
gener
type
nhp
anim
develop
febril
ill
high
fever
anorexia
weight
loss
unrespons
death
observ
day
thrombocytopenia
lymphopenia
blood
coagul
abnorm
hemorrhag
observ
squirrel
monkey
also
success
infect
marv
show
typic
diseas
symptom
recent
small
nhp
model
use
marmoset
develop
recapitul
featur
human
infect
except
typic
maculopapular
rash
develop
observ
nhp
human
infect
marv
rodent
intact
immun
system
develop
diseas
infect
marv
marv
variant
musok
ravv
variant
ravn
adapt
severecombin
immunodefici
scid
mice
serial
passag
reduc
time
death
day
day
test
viru
variant
passag
scid
mouseadapt
marburgvirus
immunocompet
mice
use
establish
mous
model
ravv
ravn
marv
success
adapt
serial
passag
also
use
gener
lethal
infect
model
guinea
pig
hamster
coagul
abnorm
typic
rash
develop
hemorrhag
manifest
especi
mice
pronounc
nhp
model
review
neuropathogen
recapitul
cn
involv
describ
first
human
mvd
outbreak
germani
observ
hamster
model
clear
cn
patholog
develop
anim
model
brain
patholog
observ
mice
cynomolgu
macaqu
nevertheless
viru
isol
brain
marvinfect
marmoset
show
microhemorrhag
sequenc
comparison
rodentadapt
virus
human
marv
isol
reveal
sever
mutat
sixtyon
nucleotid
chang
mouseadapt
ravv
ravn
variant
detect
orf
np
amino
acid
chang
total
untransl
region
gp
second
studi
analyz
genom
chang
mous
adapt
nucleotid
chang
adapt
ravv
ravn
chang
marv
describ
amino
acid
chang
occur
guinea
pig
adapt
nucleotid
chang
observ
result
four
amino
acid
chang
one
chang
locat
mutat
detect
viral
polymeras
l
amino
acid
exchang
detect
mouseand
guinea
pigadapt
marv
amino
acid
asp
asn
also
first
mutat
detect
mous
adapt
ravv
ravn
marv
analyz
sequenc
serial
passag
particular
interest
shown
function
inhibitor
ifn
signal
see
viral
protein
ifn
receptorand
mice
develop
diseas
use
nonadapt
marv
highlight
import
ifn
pathway
control
mvd
virolog
serolog
molecular
diagnost
method
detect
marv
avail
includ
viru
isol
elisa
rtpcr
em
immunohistochemistri
summar
outbreak
set
mobil
laboratori
commonli
use
pcr
andor
elisa
analysi
rapid
screen
sensit
elisa
assay
develop
detect
viral
antigen
virusspecif
antibodi
use
overexpress
marv
np
gp
detect
filovirus
pcr
assay
current
avail
distinguish
differ
viru
variant
varieti
tissu
fluid
specimen
use
combin
virusspecif
primer
set
convent
rtpcr
make
detect
know
filovirus
singl
assay
possibl
sensit
quantit
detect
realtim
rtpcrbase
assay
develop
detect
marv
feasibl
realtim
rtpcr
field
success
proven
marv
outbreak
angola
use
improv
field
laboratoryadapt
rna
isol
protocol
network
european
facil
collabor
compani
qiagen
develop
first
commerci
prototyp
realtimertpcr
assay
detect
filovirus
recent
develop
assay
rt
loopmedi
isotherm
amplif
lamp
potenti
significantli
improv
field
diagnosi
marv
infect
elimin
need
pcr
machin
initi
approach
use
inactiv
viru
develop
vaccin
marv
unsuccess
contradictori
result
addit
success
protect
rodent
alway
translat
protect
nhp
exampl
inactiv
marv
protect
guinea
pig
lethal
marv
challeng
challeng
nhp
surviv
panel
differ
approach
use
order
develop
success
vaccin
marv
review
recombin
gp
express
insect
cell
dna
vaccin
base
gp
partial
protect
guinea
pig
use
combin
vaccin
result
surviv
guinea
pig
anoth
studi
complet
protect
guinea
pig
use
differ
gp
dna
vaccin
report
four
six
vaccin
nhp
surviv
challeng
marv
show
incomplet
protect
increas
dose
codonoptim
dna
vaccin
result
surviv
nhp
although
anim
develop
symptom
recov
comparison
vaccin
candid
poor
induct
virusspecif
antibodi
observ
use
dna
vaccin
codonoptim
dna
vaccin
elicit
strong
antibodi
respons
result
complet
protect
mice
clinic
symptom
observ
vaccin
candid
base
venezuelan
equin
enceph
viru
veev
replicon
system
express
either
marv
gp
along
np
gp
alon
complet
protect
guinea
pig
nhp
vaccin
base
vlp
repres
addit
candid
protect
marv
complet
protect
guinea
pig
demonstr
vlpbase
vaccin
contain
marv
gp
induct
virusspecif
antibodi
protect
vaccin
reli
function
cell
respons
wherea
deplet
cell
ablat
protect
respons
vlp
contain
marv
musok
gp
provid
crossprotect
anim
challeng
marv
ravv
ravn
guinea
pig
nhp
anoth
approach
marv
vaccin
use
viral
vector
express
marv
gp
date
two
differ
system
establish
base
replicationdefect
adenovir
vector
recombin
vsv
express
marv
gp
adenovirusbas
vaccin
success
protect
guinea
pig
nhp
provid
crossprotect
high
level
crossreact
marvspecif
igg
cell
respons
induc
indic
induct
immun
respons
preexist
immun
adenoviru
strain
might
pose
problem
success
use
human
review
vsvbase
vaccin
complet
protect
nhp
addit
proven
success
postexposur
treatment
review
singl
immun
recombin
vsv
express
marv
musok
gp
result
protect
cynomolgu
macaqu
challeng
intramuscular
inject
aerosol
exposur
protect
ravv
ravn
marv
angola
although
marvspecif
igg
produc
low
level
neutral
antibodi
detect
surprisingli
cellmedi
respons
observ
nhp
vaccin
recombin
vsv
express
marv
gp
safeti
concern
vaccin
especi
immunocompromis
individu
replicationcompet
vsv
vector
howev
vsvbase
filoviru
vaccin
studi
vsv
viremia
observ
shortli
immun
addit
vsvbase
filoviru
gp
vaccin
well
toler
protect
immunocompromis
mice
nhp
lack
neurovirul
nhp
review
crossprotect
observ
anim
vaccin
marvbas
vaccin
subsequ
challeng
ebov
combin
marv
ebov
vaccin
success
protect
virus
date
approv
treatment
avail
marv
infect
support
care
fluid
antimicrobi
blood
transfus
primari
treatment
patient
mvd
outbreak
guinea
pig
model
variou
treatment
success
reflect
prolong
surviv
increas
surviv
rate
appli
treatment
includ
cytokin
inhibit
ifn
treatment
antibodi
transfer
test
treatment
unsuccess
nhp
model
review
third
ebovinfect
nhp
surviv
howev
follow
treatment
recombin
nematod
coagul
protein
one
six
marvinfect
anim
surviv
treatment
use
antisens
technolog
block
viral
protein
express
use
phosphorodiamid
morpholino
oligom
pmo
begin
minut
marv
infect
complet
protect
nhp
addit
small
molecul
inhibitor
show
complet
protect
marvinfect
mice
administ
infect
test
nhp
vsvbase
vaccin
express
marv
gp
also
demonstr
effect
postexposur
treatment
hundr
percent
surviv
nhp
observ
vaccin
administ
minut
marv
infect
delay
time
treatment
result
incomplet
protect
although
five
six
anim
two
six
anim
still
surviv
given
treatment
day
marv
exposur
respect
postexposur
treatment
may
use
prevent
diseas
known
exposur
marv
laboratori
accid
effect
time
frame
outbreak
might
short
altern
need
